36.82 USD
+0.06 (+0.16%)
36.83 USD
+0.01 (+0.03%)
Overall HRMY gets a fundamental rating of 8 out of 10. We evaluated HRMY against 190 industry peers in the Pharmaceuticals industry. HRMY scores excellent points on both the profitability and health parts. This is a solid base for a good stock. An interesting combination arises when we look at growth and value: HRMY is growing strongly while it also seems undervalued. This makes HRMY very considerable for value and growth and quality investing!
1. Profitability
1.1 Basic Checks
- HRMY had positive earnings in the past year.
- In the past year HRMY had a positive cash flow from operations.
- Of the past 5 years HRMY 4 years were profitable.
- HRMY had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 15.37%, HRMY belongs to the top of the industry, outperforming 95.29% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 22.23%, HRMY belongs to the top of the industry, outperforming 92.67% of the companies in the same industry.
- The Return On Invested Capital of HRMY (17.20%) is better than 94.76% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for HRMY is significantly above the industry average of 12.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 15.37% | ||
| ROE | 22.23% | ||
| ROIC | 17.2% |
ROA(3y)19.12%
ROA(5y)10.08%
ROE(3y)31.57%
ROE(5y)9.53%
ROIC(3y)18.27%
ROIC(5y)15.29%
1.3 Margins
- The Profit Margin of HRMY (22.48%) is better than 91.62% of its industry peers.
- HRMY's Profit Margin has improved in the last couple of years.
- The Operating Margin of HRMY (27.32%) is better than 93.19% of its industry peers.
- HRMY's Operating Margin has declined in the last couple of years.
- With an excellent Gross Margin value of 77.70%, HRMY belongs to the best of the industry, outperforming 83.25% of the companies in the same industry.
- In the last couple of years the Gross Margin of HRMY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.32% | ||
| PM (TTM) | 22.48% | ||
| GM | 77.7% |
OM growth 3Y-2.32%
OM growth 5YN/A
PM growth 3Y21.57%
PM growth 5YN/A
GM growth 3Y-1.56%
GM growth 5Y1.26%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HRMY is creating value.
- Compared to 1 year ago, HRMY has more shares outstanding
- Compared to 5 years ago, HRMY has less shares outstanding
- HRMY has a better debt/assets ratio than last year.
2.2 Solvency
- HRMY has an Altman-Z score of 5.48. This indicates that HRMY is financially healthy and has little risk of bankruptcy at the moment.
- HRMY has a Altman-Z score of 5.48. This is in the better half of the industry: HRMY outperforms 74.35% of its industry peers.
- The Debt to FCF ratio of HRMY is 0.57, which is an excellent value as it means it would take HRMY, only 0.57 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 0.57, HRMY belongs to the best of the industry, outperforming 96.86% of the companies in the same industry.
- HRMY has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
- HRMY has a Debt to Equity ratio (0.18) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.57 | ||
| Altman-Z | 5.48 |
ROIC/WACC1.81
WACC9.5%
2.3 Liquidity
- HRMY has a Current Ratio of 3.75. This indicates that HRMY is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of HRMY (3.75) is comparable to the rest of the industry.
- A Quick Ratio of 3.72 indicates that HRMY has no problem at all paying its short term obligations.
- HRMY's Quick ratio of 3.72 is in line compared to the rest of the industry. HRMY outperforms 59.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.75 | ||
| Quick Ratio | 3.72 |
3. Growth
3.1 Past
- HRMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.71%, which is quite impressive.
- HRMY shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 44.61% yearly.
- The Revenue has grown by 21.13% in the past year. This is a very strong growth!
- The Revenue has been growing by 160.13% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)50.71%
EPS 3Y44.61%
EPS 5YN/A
EPS Q2Q%10.13%
Revenue 1Y (TTM)21.13%
Revenue growth 3Y32.77%
Revenue growth 5Y160.13%
Sales Q2Q%28.71%
3.2 Future
- The Earnings Per Share is expected to grow by 35.10% on average over the next years. This is a very strong growth
- HRMY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.79% yearly.
EPS Next Y30.39%
EPS Next 2Y29.73%
EPS Next 3Y25%
EPS Next 5Y35.1%
Revenue Next Year21.02%
Revenue Next 2Y18.62%
Revenue Next 3Y16.71%
Revenue Next 5Y14.79%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 11.58, which indicates a very decent valuation of HRMY.
- Compared to the rest of the industry, the Price/Earnings ratio of HRMY indicates a rather cheap valuation: HRMY is cheaper than 89.01% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.21, HRMY is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 8.72, the valuation of HRMY can be described as reasonable.
- Based on the Price/Forward Earnings ratio, HRMY is valued cheaply inside the industry as 90.05% of the companies are valued more expensively.
- HRMY is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.98, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.58 | ||
| Fwd PE | 8.72 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HRMY indicates a rather cheap valuation: HRMY is cheaper than 94.24% of the companies listed in the same industry.
- HRMY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HRMY is cheaper than 96.34% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.14 | ||
| EV/EBITDA | 6.38 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- HRMY has an outstanding profitability rating, which may justify a higher PE ratio.
- HRMY's earnings are expected to grow with 25.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y29.73%
EPS Next 3Y25%
5. Dividend
5.1 Amount
- No dividends for HRMY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
HARMONY BIOSCIENCES HOLDINGS / HRMY FAQ
Can you provide the ChartMill fundamental rating for HARMONY BIOSCIENCES HOLDINGS?
ChartMill assigns a fundamental rating of 8 / 10 to HRMY.
What is the valuation status of HARMONY BIOSCIENCES HOLDINGS (HRMY) stock?
ChartMill assigns a valuation rating of 9 / 10 to HARMONY BIOSCIENCES HOLDINGS (HRMY). This can be considered as Undervalued.
Can you provide the profitability details for HARMONY BIOSCIENCES HOLDINGS?
HARMONY BIOSCIENCES HOLDINGS (HRMY) has a profitability rating of 8 / 10.
What are the PE and PB ratios of HARMONY BIOSCIENCES HOLDINGS (HRMY) stock?
The Price/Earnings (PE) ratio for HARMONY BIOSCIENCES HOLDINGS (HRMY) is 11.58 and the Price/Book (PB) ratio is 2.54.
What is the earnings growth outlook for HARMONY BIOSCIENCES HOLDINGS?
The Earnings per Share (EPS) of HARMONY BIOSCIENCES HOLDINGS (HRMY) is expected to grow by 30.39% in the next year.